Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects.

Sitbon, O

Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects. [electronic resource] - European journal of clinical investigation Sep 2006 - 25-31 p. digital

Publication Type: Journal Article

0014-2972

10.1111/j.1365-2362.2006.01685.x doi


Adolescent
Adult
Antihypertensive Agents--administration & dosage
Bosentan
Child
Drug Therapy, Combination
Exercise Test--methods
Female
Heart Defects, Congenital--complications
Humans
Hypertension, Pulmonary--complications
Male
Middle Aged
Prostaglandins, Synthetic--therapeutic use
Pulmonary Circulation--drug effects
Retrospective Studies
Sulfonamides--administration & dosage
Treatment Outcome
Vascular Resistance--drug effects
Walking--physiology